Log in to save to my catalogue

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and l...

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and l...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4936296

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review

About this item

Full title

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2016-07, Vol.16 (1), p.400, Article 400

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) mutations that activate the PI3K/AKT signaling pathway have been observed in several types of carcinoma and have been associated with patient prognosis. However, the significance of PIK3CA mutations in gastric cancer remains unclear. This retrospective study investigat...

Alternative Titles

Full title

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4936296

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4936296

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-016-2422-y

How to access this item